Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000681134 | SCV000808592 | uncertain significance | not provided | 2022-12-07 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29493581) |
Ambry Genetics | RCV002386154 | SCV002694156 | uncertain significance | Cardiovascular phenotype | 2023-12-11 | criteria provided, single submitter | clinical testing | The p.A321T variant (also known as c.961G>A), located in coding exon 7 of the SOS1 gene, results from a G to A substitution at nucleotide position 961. The alanine at codon 321 is replaced by threonine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002467990 | SCV002763480 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467989 | SCV002763481 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |